Rationale: Tumor-to-tumor metastasis is an uncommon phenomenon, and the tumor metastatic to mesenchymal tumor is extremely rare. To our knowledge, this is the first case of lung adenocarcinoma metastasizing to fibrous histiocytoma.
Introduction
Tumor-to-tumor metastasis is an uncommon phenomenon which was first reported by Fried in 1930 . [1] Histopathologically, a definite tumor-to-tumor metastasis should meet the following 4 criteria proposed by Campbell et al [2] : >1 primary tumor; the recipient tumor is a true neoplasm (either benign or malignant), and histologically different from the primary tumor; the metastatic tumor is a true metastasis, collision tumor and embolism of neoplastic cells in the recipient tumor should be excluded; and the recipient tumor should not be lymphoreticular malignant tumors. Based on the scattered reports and autopsy series review, the most common "donor" tumors were breast cancer and lung cancer and the most common "recipient" tumors were renal cell carcinoma, thyroid carcinoma, adrenocortical adenoma, and meningioma. [3] [4] [5] [6] [7] [8] [9] [10] Tumor metastatic to mesenchymal tumor was extremely rare. Sporadic cases of tumor metastatic to renal angiomyolipoma, [9, 11, 12] schwannoma, [13] [14] [15] [16] neurofibroma, [17] lipoma, [18] and solitary fibrous tumor [19, 20] have been reported. To our knowledge, there were no reports described the fibrous histiocytoma as the "recipient" tumor of tumor-to-tumor metastasis. Tumor microenvironment (so called seed and soil theory) was proposed to explain the reason why tumor-to-tumor metastasis favored to occur in specific tumor, such as renal cell carcinoma, thyroid carcinoma, adrenocortical adenoma, and meningioma. Likewise, lipid-rich organs were favorable for implantation of metastatic cancer. In the current case, we noticed the accumulation of numerous lipid-filled foam cells within the tumor, which also created a lipid-rich microenvironment. This abnormal tumor lipid metabolism might be a potential reason for modifying premetastatic niche, and therefore created a tumor microenvironment suitable for metastasis.
Without a comprehensive clinical history, image examination, this case might be misdiagnosed as atypical fibroxanthoma or giant cell fibroblastoma and therefore caused inappropriate treatment or evaluation.
Case presentation

Ethic approval
The study was approved by the China Medical University Institutional Review Board for human studies. The ethical board approval number is LS [2018] 016. Written informed consent was obtained from the patient for use of her clinical records in our study.
Clinical history
A 58-year-old Chinese woman was admitted to our hospital with a complaint of progressive enlargement of a mass in the right upper arm. She felt no pain, heat (localized warmth), redness, and swelling since the illness began. Half a year ago, the patient was short of breath and felt chest stuffiness. Pulmonary computed tomography (CT) scanning was performed and found a mass with soft tissue density (5.4 Â 2.6 cm; CT value: 45 HU) near the hilm of inferior lobe of left lung. Calcification was observed within the tumor. The CT value was 67 HU after enhancement. Distal bronchial cut-off sign of left inferior lobe was observed (Fig. 1A-C) . She was diagnosed with lung adenocarcinoma by bronchoscopic biopsy and received 4 cycles of vinoreltraye + cisplatinum (NP) chemotherapy program. She found that the elbow mass grew rapidly within a week since the end of chemotherapy. Ultrasound revealed a mass (2.75 Â 2.58 Â 2.77 cm) with relative clear boundary in the right upper arm near elbow joint (Fig. 1D) . Ultrasound showed uneven echoes, and blood flow signals within the mass and suspected for malignancy because of the lobulated structure within the mass and high internal tension. The patient underwent a total mass resection and the mass was completely excised. After complete sampling, we rendered a diagnosis of lung adenocarcinoma metastasizing to fibrous histiocytoma. The primary lung adenocarcinoma shared similar histological morphologies with those of subcutaneous metastatic sites. The patient died of multiple organ failure after 10 months since she was diagnosed as lung adenocarcinoma. The final diagnosis was pulmonary adenocarcinoma accompanied with distant metastasis (metastasizing to elbow fibrous histiocytoma), Stage IVB.
Immunohistochemical staining
The intramuscular mass in the right upper arm was completely sampled following the routine guideline of sampling 1 block/cm Medicine of tumor. All specimens and samples of fine needle aspiration biopsy were fixed in 10% formalin and embedded in paraffin. A series of 4-mm-thick sections was cut from each paraffinembedded block. Commercially available prediluted monoclonal antibodies directed against epithelial membrane antigen (EMA), Cytokeratin AE1/AE3 (AE1/AE3), CD68, S-100, smooth muscle actin (SMA), Desmin, cytokeratin 7 (CK7), thyroid transcription factor-1 (TTF-1), Vimentin, and Ki-67 were purchased from Mai Xin Inc., Fuzhou, China. Immunohistochemistry staining was performed using the streptavidin-peroxidase system (Ultrasensitive; Mai Xin Inc., Fuzhou, China) according to the manufacturer's instructions. The primary antibody was replaced with phosphate-buffered saline for negative controls.
Morphological and immunohistochemical findings
At low magnification, the tumor is circumscribed with sharp demarcation from surrounding adipose tissues by a thin fibrous capsule ( Fig. 2A and B) . The tumor was composed of blind, spindle cells, and amount of foam cells and arranged in lobulated or nodule pattern ( Fig. 2C and D) . Meanwhile, large areas of necrosis were observed even under low magnification in the central of nodule. At high magnification, some atypical cells arranged in nests, cords, or even formed poorly glandular or papillary structures. These atypical cells inserted among the spindle fibrous histocytes and foam cells ( Fig. 2E and F) . Atypical mitosis may be observed in this region (Fig. 2G) . Focally, the tumor cells arranged in cords and caused the confusion with proliferative vascular endothelial cells (Fig. 2H ). In addition, multinuclear giant cells and hemosiderin deposition were easy to observe.
The epithelioid atypical cells arranged in nest, cord or poorly glandular, or papillary structures were diffusely positive for AE1/ AE3 (Fig. 3A and B) , TTF-1 (Fig. 3C) , Napsin-A, and CK7, but 
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Medicine negative for Vimentin ( Fig. 3D and E) , SMA, Desmin, S-100, and CD68 (Fig. 3F) . The immunostaining results supported the diagnosis of metastatic lung adenocarcinoma. On the other hand, the blind, spindle cells, foam cells, and multinuclear giant cells were diffusely positive for Vimentin ( Fig. 3D and E) , CD68 (Fig. 3G) , and focally positive for SMA, but negative for AE1/ AE3, EMA, TTF-1, Napsin-A, CK7, and S-100, and supported the diagnosis of benign fibrous histiocytoma. The Ki-67 labeling index was approximately 60% in the adenocarcinoma component (Fig. 3H ) and was <2% in the region of fibrous histiocytoma.
Discussion
As described in the introduction, rendering a diagnosis of tumorto-tumor metastasis has strict criteria. In clinical practice, a definite diagnosis is hard to achieve because of the difficulty to acquire the sample of primary lesion or unnecessary to do so as the tumor has already metastasized to multiple organ and the patient cannot benefit from it. In particular, the primary tumor may be found occasionally in autopsy. Therefore, the real incidence of the tumor-to-tumor metastasis is underestimated. Although some mesenchymal tumors have been reported as recipient tumors in tumor-to-tumor metastasis, fibrous histiocytoma has never been reported to our knowledge. As reported in the past, the most common recipient malignant tumors are renal cell and thyroid carcinoma, while the benign counterparts are adrenocortical adenoma and meningioma. [21] These tumors are either rich in blood or rich in lipids. Hypervascularity, tumor microenvironment (so called seed and soil theory), cell-cell adhesion, and complex interactions involving hormonal factors have been used to explain this organ specificity. [22] Abnormal lipid metabolism is a fairly new field among tumor microenvironment and has received attention recently. [23] It has been recognized as an important metabolic rewiring phenomenon in tumor cells. The lipid accumulation not only provide energy storage for tumor cells, but also involve in metastatic cascade by modifying premetastatic niche, and therefore create a suitable microenvironment and facilitate metastasis. [23] It is worth noting that the accumulation of lipid-filled "foam cell" macrophages is observed within the recipient tumor (Fig. 1D) . Likewise, the other common recipient tumors, such as renal cell carcinoma and adrenocortical adenoma are also characterized by the abundance of cytoplasmic lipid droplets. This leads us to speculate that the abnormal tumor lipid metabolism may be a potential reason for modifying premetastatic niche, and therefore create a tumor microenvironment suitable for metastasis.
In the current case, the differential diagnosis included "collision tumor," atypical fibroxanthoma, and giant cell fibroblastoma. Ultrasound image and the whole picture at low manifestation showed that the component of adenocarcinoma neither invaded from the extracapsular tissue, nor adjoined to the fibrous histiocytoma. Therefore, a diagnosis of "collision tumor" could be excluded. The obvious necrosis and prominent cell atypia did not support the diagnosis of atypical fibroxanthoma and giant cell fibroblastoma, although the images at low magnification may be misleading. Detailed clinical history and rational immunohistochemical pattern let us have the confidence to make a diagnosis of lung adenocarcinoma metastasizing to fibrous histiocytoma. In addition, scattered osteoclast-like giant cells is observed within the tumor. Pan-CK and CD68 staining indicate that these cells are not multicellular giant cell of adenocarcinoma. We also review the slide of the previous biopsy. These 2 sites of adenocarcinoma share similar histological features.
The patient died of multiple organ failure after 10 months since she was diagnosed as lung adenocarcinoma. This prognostic data again indicate that tumor-to-tumor metastasis has a poor prognosis than "collision tumor." [24] Tumor-to-tumor metastasis is probably a potent or local presentation of multiple organ metastasis and the prognosis depends on the malignancy of the primary tumor.
Here, we reported a first case of lung adenocarcinoma metastasizing to fibrous histiocytoma. Our report is a supplement for the recipient tumor type in tumor-to-tumor metastasis.
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